Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic Review
{{output}}
Background: Checkpoint inhibitors (CPI) have now been established as standard agents in the management of patients with metastatic renal cell carcinoma (mRCC). Given the unique toxicity profiles of CPIs, a detailed understanding ... ...
